LEP and colorectal carcinoma: The observed correlations of FABP-4 with a variety of biomarkers of inflammation, metabolism, blood lipids, adipokines, antioxidative capacity, and immune function (with strongest correlations observed for leptin and the antioxidant biomarker FRAP), some of which also have been previously associated with CRC risk, suggest that circulating FABP-4 is an integrative marker of various biological processes.